11 August 2025
Dual-Sourcing your Drug Product Fill Finish
The past few years have revealed the fragility of global drug product supply chains. For pharmaceutical companies, particularly those introducing...
23 May 2025
Key considerations for a successful tech transfer
Key considerations for a successful tech transfer Speed is essential in today’s pharmaceutical development. Bringing a new drug to market...
18 December 2023
Challenges to Overcome When Fill-Finishing High Potency, Next-Generation Oncological Drug Products
Novel biologic therapies have shown success across a wide range of disease areas, particularly for the treatment of oncological indications....
7 December 2023
The Critical Role of Quality Control Testing in Aseptic Fill-Finish Manufacturing
Alison Clayton, Strategic Projects Director, explores the pivotal role of effective QC testing services in progressing pharmaceutical products to the...
26 October 2023
Pioneering the future of oncology with innovative drug therapies
The potential side effects of traditional anticancer drugs and the new emerging modalities that are designed to elicit improved targeted...
12 October 2023
EU Annex 1 Revision: Q&A Session with Stephen Clarke, QP
EU GMP and Annex 1: The New Version In this edition, we speak with Symbiosis Qualified Person, Stephen Clarke to...
28 July 2023
Key questions to evaluate when assessing CMO suppliers.
Introduction It’s estimated that even drug development companies with in-house aseptic fill finish capacity still choose to outsource 39% of...
27 June 2023
The virtues, variations and values of flexibility within a partner CMO
In recent years the healthcare landscape has evolved at a significant pace, particularly regarding the development of complex drugs and...
20 June 2023
Lyophilisation: Stabilise your drug product formulations.
In this blog, we will explore lyophilisation and discuss how it’s typically incorporated into current manufacturing processes by expert contract...
4 May 2023
New Drug Modalities: An Insight into the Future Therapeutic Landscape Opportunities
The biopharmaceutical industry is experiencing a paradigm shift in the treatment of complex diseases, particularly oncology, thanks to a surge...
13 April 2023
The Increasing Requirement for Aseptic Fill-Finish Manufacturing
Introduction With the global spend on medicines projected to increase to $1.29tn in 2027[i], contract manufacturing organisations (CMOs) are experiencing...
20 March 2023
Symbiosis Meet the Team: No.5 – Linda Merrilees, Business Development Manager
In this edition of the Symbiosis Meet the Team, we sit down with our newly appointed Business Development Manager, Linda...